arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

InnovAge Holding Corp.

INNV
$9.09 ▼ -0.70 (-7.15%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
29 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
37
Health
Weak
Neutral
auto_awesome

Analytical Summary

InnovAge Holding Corp. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.2B
Dividend Yield —
Revenue Growth 12.1% ↘
Op. Margin 7.6% ↗
ROIC 5.3% ↗
FCF / Share $0.19
Trailing P/E 64.9x
Price / Book 4.9x
FCF Yield 2.1%
Debt / Equity 0.18
info Valuation on last close. End-of-day price, Nov 5, 2026.

29-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$264.76M
↑ +12.1% —
Net Income Profit after all expenses
$19.55M
↑ +143.8% —
Operating Margin Operating profit as % of sales
7.6%
↑ +96.5% 26th
FCF / Share Free cash flow per share
$0.19
↑ +76.2% —
Long-Term Debt Long-term obligations
$44.98M
↓ -7.9% —

Health Breakdown

Profitability ↑
31
Returns ↑
40
Financial Health ↓
58
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 8 years · 29 quarters